Cancer

Recent advancements in the development of ESR1 inhibitors offer fresh optimism in the fight against hormone receptor-positive/HER2-negative metastatic breast cancer. Innovative treatments, including selective estrogen receptor degraders and the use of liquid biopsies, are revolutionizing the treatment landscape. Analyzing these progressions uncovers encouraging avenues to elevate patient care and boost survival rates in the continuing […]

Metastatic breast cancer presents significant challenges, yet various treatment options provide hope and improved quality of life for those affected. Personalized approaches consider tumor biology, location of metastasis, and genetic factors to tailor effective strategies. Recent advancements in drug therapies and genetic testing play a crucial role in managing the disease, while supportive care aims […]